查詢結果分析
來源資料
相關文獻
- Antiviral Therapy for Epstein-Barr Virus-Associated Diseases
- 端粒酶核酸分子之生理意義及藥物開發
- 常見柴胡中藥材品種之分子鑑定
- The Preparation of RNA-Dependent RNA Polymerase Complex from Virus Infected Plants
- 人類幹細胞研究的法議題
- Clinical Application of Two New Serological Tests of Epstein-Barr Virus in Nasopharyngeal Carcinoma
- 逢機複製多態性核苷酸在畜產之應用
- 分子流行病學:核酸複製及基因序列分析之應用
- Origin and Molecular Evolution of the X-Linked Duplicate Color Vision Genes in Howler Monkeys
- 惡性淋巴瘤的骨髓侵犯:EB病毒糖核糖1(EBER1)原位雜交法為一有用的參數
頁籤選單縮合
題 名 | Antiviral Therapy for Epstein-Barr Virus-Associated Diseases=EB病毒相關疾病之抗病毒藥物之治療 |
---|---|
作 者 | 林榮寵; | 書刊名 | 慈濟醫學 |
卷 期 | 17:1 民94.02 |
頁 次 | 頁1-10+55 |
分類號 | 414.84 |
關鍵詞 | EB病毒; 複製; 核; 酸衍生物; 抗病毒藥物治療; 潛伏性感染; EBV; Replication; Nucleoside analogs; Antiviral therapy; Latent infection; |
語 文 | 英文(English) |
中文摘要 | EB病毒感染之最大特性是會造成潛伏性之感染。目前之抗病毒藥物可以很有效地抑制EB病毒之複製,但對於潛伏性之感染,這些籠統之抗病毒藥物卻無法發揮效力。因此,有效治療EB病毒感染之新藥物有待進一步研發。本文提供綜合性之評述:EB病毒感染之病毒學、藥物之作用機制、抑制EB病毒複製、藥物之研究近況、報導不同作用機制之新藥物。最後,提供一嶄新之治療潛伏感染之技術。 |
英文摘要 | A unique feature of Epstein-Barr virus (EBV) infection is its ability to establish latency after infection. Replication of EBV can be effectively inhibited by available antiviral drugs, but latent EBV infection is unaffected by any of these conventional antiviral agents regardless of the mode of action. Despite the availability of effective antiviral drugs, treatment for EBV infection remains undeveloped. This article provides an overview on the virology of EBV infection, the mechanisms of drug action, current status of nucleoside analogs against EBV replication, and other classes of drug with different target sites, and moves toward establishing a novel approach of latent EBV infection. |
本系統中英文摘要資訊取自各篇刊載內容。